A potential way to reduce the risk of postpartum breast cancers

Breast cancers that emerge in young women within a few years after pregnancy are strikingly more dangerous. A new study suggests that the common pain reliever ibuprofen might work as a preventive...

A new way to guide cancer immune therapy

Scrutinizing the immune cells infiltrating a tumor may reveal the cancer's vulnerability or resistance to immune-based therapies. Cancer immune therapies have delivered life-saving, long-lasting...

For rare tumors, a far-reaching trial of immunotherapy

The first federally funded clinical trial of immunotherapy for rare cancers launched this week under the auspices of SWOG, the research consortium headquartered at the OHSU Knight Cancer...

Instant message to cancer cells: time to die

Cancer researchers have uncovered a signaling link – like a Snapchat between cells – that could be used to make tumors more vulnerable to therapy....

Immunotherapy takes a new turn for life-threatening prostate cancer

At the recent European Society for Medical Oncology meeting, OHSU oncologist Julie Graff, M.D., presented the first evidence of meaningful clinical activity for PD-1 blockade in men with...

Uncovering the ways cancer manipulates immune cells

Cancer cells have a remarkable ability to reshape their surroundings to gain survival advantages. A developing tumor can, for instance, attract and reprogram immune white blood cells to help the...